Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 92,800
-1,000 (-1.07%)
At close: Apr 10, 2026
Yuhan Market Cap
Yuhan has a market cap or net worth of 6.97 trillion as of April 10, 2026. Its market cap has decreased by -25.37% in one year.
Market Cap
6.97T
Enterprise Value
6.99T
Revenue
2.19T
Ranking
n/a
PE Ratio
36.08
Stock Price
92,800.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 6.97T, an increase of 2,908.60%. That is a compound annual growth rate of 14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 6.97T | -16.91% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.18T |
| Celltrion Pharm | 2.42T |
| Hanall Biopharma | 2.39T |
| Daewoong Pharmaceutical | 1.70T |
| GC Biopharma | 1.65T |
| DongKook Pharmaceutical | 1.29T |
| Chong Kun Dang Pharmaceutical | 1.15T |
| Daewoong | 907.77B |